AI-Powered Drug Discovery

From Computation to Clinic

ThalosForge combines advanced computational docking, reinforcement learning, and wet lab validation to accelerate drug repositioning and combination therapy development.

10x
Faster Discovery
70%+
Hit Rate
$2.6B
Cost Reduction
3-5yr
Time Savings

Integrated Discovery Platform

Complete pipeline from computational prediction to validated therapeutic candidates

🧬

FPDE Engine

Computational docking engine that processes AutoDock Vina results, ranks drug-receptor pairs by binding affinity, and generates explainable WhyCards.

Molecular Docking β€’ Affinity Ranking
πŸ€–

ATOE Optimizer

Reinforcement learning system for drug combination optimization. Multi-objective RL balances efficacy, toxicity, and manufacturability.

Deep RL β€’ Multi-Objective Optimization
πŸ’‘

WhyCardsβ„’

Explainable AI that provides transparent reasoning for each prediction. Essential for regulatory submissions and clinical decision-making.

XAI β€’ Regulatory Ready

Discovery Pipeline

End-to-end workflow from AI prediction to market-ready therapeutics

01
In Silico
FPDE docking against protein targets
02
Ranking
AI prioritization & WhyCard generation
03
Optimization
ATOE combination strategies
04
Validation
Wet lab testing with research partners
05
Clinic
IND filing & clinical trials

Partnership Opportunities

Seeking strategic partnerships to accelerate therapeutic development

Academic Institutions

Wet lab validation partnerships with leading research centers

Clinical Research

Collaborations for preclinical studies and translational research

Pharma Companies

Platform licensing and drug discovery collaborations

Investment Partners

Strategic funding for platform development and validation

Ready to Transform Drug Discovery?

Partner with ThalosForge to accelerate your therapeutic development. From computational predictions to clinical candidates, we provide the complete platform.

Technical Documentation